✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Bristol-Myers Squibb Co

Common Name
Bristol-Myers Squibb
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
34,100
Ticker
BMY
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Bristol-Myers Squibb Company is a renowned pharmaceutical corporation engaged in the discovery, development, and distribution of innovative medicines. The company's core focus lies in providing therap...

Bristol-Myers Squibb's Waste Data Preview

In 2023, Bristol-Myers Squibb conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023202220212020 - 2017
Total Waste Generated
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
Total Waste Recovered
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Total Hazardous Waste Generated
0000000
0000000
Copy/Paste is a PRO feature.
0000000
Non-Hazardous Waste Disposed
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Limited Data Preview
You are viewing a limited preview of Bristol-Myers Squibb’s Waste Management dataset. The full dataset, available for download, includes total waste generated, broken down by hazardous and non-hazardous streams, along with reported recovery and disposal figures with historical coverage back to undefined.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Bristol-Myers Squibb’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bristol-Myers Squibb’s data sources below and access millions more through our Disclosure Search.

a. Bristol-Myers Squibb's ESG Report 2023

Insights into Bristol-Myers Squibb's Waste Treatment Practices

In 2023, Bristol-Myers Squibb generated a total of 11,479metric tonnes of waste.a

Of this amount, 51.62% of Bristol-Myers Squibb's total waste generated was recovered through methods such as recycling, reuse, or composting, while 48.38% was disposed of through landfilling, incineration, or combustion.a

Bristol-Myers Squibb's Waste Recovery Rate

52%

How much of Bristol-Myers Squibb's waste is recycled or recovered?

In 2023, Bristol-Myers Squibb reported a total waste generation of 11,479 metric tonnes, of which 51.62% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Bristol-Myers Squibb is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a

Has Bristol-Myers Squibb reduced its environmental waste footprint over time?

Since 2023, Bristol-Myers Squibb's total waste generation has decreased by 14.69%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.a

Over the same period, Bristol-Myers Squibb's waste recovery rate increased by 12.29%.a

Bristol-Myers Squibb’s Waste Recovery vs. Disposal Over Time

2022202303.5 k7 k10.5 k14 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into Bristol-Myers Squibb’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Bristol-Myers Squibb generated a total of 11,479 metric tonnes of waste.a

Of this amount, 15.48% of Bristol-Myers Squibb's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.32.9% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.The remaining 51.62% was either treated using unspecified methods or not clearly categorized.a

Bristol-Myers Squibb’s Hazardous vs Non-Hazardous Waste Over Time

2022202302 k4 k6 k8 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Bristol-Myers Squibb reduced the environmental impact of its waste?

Since 2023, Bristol-Myers Squibb's total waste generation has decreased by 14.69%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.a

a

Overall, Bristol-Myers Squibb's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a

Want Full Access to Bristol-Myers Squibb's Waste Management Dataset?
Sign Up